Geeta Nargund is Head of Reproductive Medicine at St George’s Hospital and Medical Director of the Centre of Reproduction and Advanced Technology, London, UK. She is also Chief Executive of the Health Education Research Trust (HER Trust) UK and the President of ISMAAR (International Society for Mild Approaches in Assisted Reproduction). She has published extensively on the role of advanced ultrasound technology in reproductive medicine. She is the chief author of the first scientific paper on cumulative live birth rates of natural (unstimulated) cycle IVF and on one-stop fertility diagnosis using ultrasound technology. Her research interests include minimal approaches in assisted reproduction and advanced ultrasound technology.
The following link is to a paper written for RBM online, detailing research into the use of low-dose HCG in the prevention of OHSS:
http://www.stgeorgeshouseclinic.org.uk/RB2843.pdf
First Step - Clomid
13 years ago
Severe OHSS is a rare but potentially fatal condition associated with conventional IVF treatment. In women at high risk of OHSS, a low dose of Human chorionic gonadotropin(HCG) appears to prevent the development of OHSS without compromising success rates.
ReplyDelete